§ Funding Round
Series A funding round for Enlaza Therapeutics raising $100M in April 2024
Series A funding round for Enlaza Therapeutics raising $100M in April 2024
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
Samsara BioCapital | — | — |
| Organization | — | |
| Organization | — | |
Bregua Corporation | — | — |
| Angel | James Topper | |
stephen squintoLEAD | Angel | stephen squinto |
| Angel | shelley chu | |
| Organization | — | |
| Organization | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$161M
Top Valuation
-
Enlaza Therapeutics raised $100M in a Series A round.
The round was announced on 04/01/24.
The round was led by stephen squinto.
